Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arno Therapeutics (ARNI)
:ARNI
Holding ARNI?
Track your performance easily
ARNI Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume800.00
Average Volume (3M)0.00
Market Cap
$4.93K
Enterprise ValueN/A
Total Cash (Recent Filing)$6.68M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-15.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding49,350,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Standard Deviation17.49
R-Squared0.00007
Alpha3.29
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
8.47% Other Institutional Investors
91.53% Public Companies and
Individual Investors
ARNI FAQ
What was Arno Therapeutics’s price range in the past 12 months?
Arno Therapeutics lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Arno Therapeutics’s market cap?
Arno Therapeutics’s market cap is $4.93K.
When is Arno Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Arno Therapeutics’s earnings last quarter?
Currently, no data Available
Is Arno Therapeutics overvalued?
According to Wall Street analysts Arno Therapeutics’s price is currently Overvalued.
Does Arno Therapeutics pay dividends?
Arno Therapeutics does not currently pay dividends.
What is Arno Therapeutics’s EPS estimate?
Arno Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Arno Therapeutics have?
Arno Therapeutics has 49,350,000 shares outstanding.
What happened to Arno Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Arno Therapeutics?
Currently, no hedge funds are holding shares in ARNI
---
Company Description
Arno Therapeutics
Arno Therapeutics, Inc. is a biopharmaceutical company, which focuses on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs. The company was founded in March 2000 and is headquartered in Flemington, NJ.
---
Agenus
―
Northwest Biotherapeutics
―
Geron
―
Cyclacel Pharmaceuticals
―
Inovio Pharmaceuticals
―
Marker Therapeutics
―
---